shortagewatch

Home / Cardiovascular system / Candesartan and Diuretics

ATC C09DA06 · Agents Acting On The Renin-Angiotensin System

Candesartan and Diuretics shortage

As of 31 Oct 2026, Candesartan and Diuretics has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 10 products.

Countries3/5
Products10packs or presentations
Short since12 Dec 20223.9 years ago
Earliest return24 Nov 2026company estimate
No return date5products
Main reasonManufacturing problem

Timeline

ItalySpainAustria
202320242025202620282029CANDESARTAN E IDROCLOROTIAZIDE ZENTIVA ITALICANDESARTAN E IDROCLOROTIAZIDE ZENTIVA ITALIACANDESARTAN E IDROCLOROTIAZIDE MYLANCANDESARTAN E IDROCLOROTIAZIDE MYLANCANDESARTAN E IDROCLOROTIAZIDE MYLAN GENERICCANDESARTAN E IDROCLOROTIAZIDE MYLAN GENERICSCANDESARTAN E IDROCLOROTIAZIDE MYLANCANDESARTAN E IDROCLOROTIAZIDE MYLANCANDESARTAN/HIDROCLOROTIAZIDA VIATRIS 16 MG/CANDESARTAN/HIDROCLOROTIAZIDA VIATRIS 16 MG/12,5 MG COMPRIMIDOS EFG, 28 comprimidosCANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORCANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORMON 8 MG/12.5 MG COMPRIMIDOS EFG, 28 comprimidosCANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORCANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORMON 32 MG/12.5 MG COMPRIMIDOS EFG , 28 comprimidosBlopress Plus 32 mg/25 mg - Tabletten, 28 StBlopress Plus 32 mg/25 mg - Tabletten, 28 StückBlopress Plus 32 mg/12,5 mg - Tabletten, 28 Blopress Plus 32 mg/12,5 mg - Tabletten, 28 StückCandesartan/HCT 1A Pharma 32 mg/12,5 mg - TaCandesartan/HCT 1A Pharma 32 mg/12,5 mg - Tabletten, 30 Stücktoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITCANDESARTAN E IDROCLOROTIAZIDE ZENTIVA ITALIAZENTIVA ITALIA S.R.L.12 Dec 2022not givenManufacturing problem
Problemi produttivi: forniture discontinue
ITCANDESARTAN E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.9 Feb 2026not givenManufacturing problem
Problemi produttivi
ITCANDESARTAN E IDROCLOROTIAZIDE MYLAN GENERICSMYLAN S.P.A.15 May 2026not givenManufacturing problem
Problemi produttivi
ITCANDESARTAN E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.17 Aug 2026not givenManufacturing problem
Problemi produttivi
ESCANDESARTAN/HIDROCLOROTIAZIDA VIATRIS 16 MG/12,5 MG COMPRIMIDOS EFG, 28 comprimidosViatris Limited5 Apr 20268 Mar 2027Not stated
ESCANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORMON 8 MG/12.5 MG COMPRIMIDOS EFG, 28 comprimidosLaboratorios Normon S.A.12 Oct 202624 Nov 2026Not stated
ESCANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORMON 32 MG/12.5 MG COMPRIMIDOS EFG , 28 comprimidosLaboratorios Normon S.A.27 Oct 202624 Nov 2026Not stated
ATBlopress Plus 32 mg/25 mg - Tabletten, 28 StückCheplapharm Arzneimittel GmbH6 Dec 20255 Dec 2028Commercial decision or withdrawal
Vorübergehende Einstellung des Inverkehrbringens
ATBlopress Plus 32 mg/12,5 mg - Tabletten, 28 StückCheplapharm Arzneimittel GmbH9 Apr 20268 Apr 2029Commercial decision or withdrawal
Vorübergehende Einstellung des Inverkehrbringens
ATCandesartan/HCT 1A Pharma 32 mg/12,5 mg - Tabletten, 30 Stück1 A Pharma GmbH27 Oct 2026not givenManufacturing problem
Kapazitätsengpässe bei der Herstellung

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply